Neil Steven - Concepedia

Author

Neil Steven

Also Known As

Jannie Marie Bülow Sand, N M Steven, N STEVEN, N Steven, N. M. Steven, N. Steven, N.M. Steven, Neil M Steven, Neil M. Steven, Neil Matthew Steven

162

Publications

7.8K

Citations

H-Index

Concepts

All Affiliations

University of Birmingham Cancer Research UK Clinical Trials Unit Cancer Research UK Queen Elizabeth Hospital Birmingham Royal Marsden Hospital

About

Neil Steven is an author at University of Birmingham specializing in medicine, immunology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	31	3.3K
2	Cell Biology	8	8	1.5K
3	Health Sciences	3	3	201
4	Head And Neck Surgery	1	1	45
5	Health Policy	1	1	24

Neil Steven

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo Margaret Callan, Linda Tan, N. E. Annels, The Journal of Experimental Medicine	1998	893
A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor Jennifer Hu, Robert S. Coffin, C. J. Davis, Clinical Cancer Research	2006	561
Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state Rosemary J. Tierney, Neil Steven, Lawrence S. Young, Journal of Virology Viral ReplicationBlood Mononuclear CellsLatent InfectionImmunologyPathology	1994	492
Large clonal expansions of CD8+ T cells in acute infectious mononucleosis Margaret Callan, Neil Steven, P. Krausa, Nature Medicine Immunological MemoryAutoimmune DiseaseT-regulatory CellHematologyImmunology	1996	481
Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas Michael Cullen, Neil Steven, Lucinda Billingham, New England Journal of Medicine	2005	421
Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus–induced Cytotoxic T Cell Response Neil Steven, Nicola Annels, Anita Kumar, The Journal of Experimental Medicine Ebv Disease PathogenesisImmunologyPathologyAntigen ProcessingImmediate Early	1997	349
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma† Daniel H. Palmer, Rachel Midgley, Noweeda Mirza, Hepatology	2008	280
Human CD8 + T Cell Responses to EBV EBNA1: HLA Class I Presentation of the (Gly-Ala)–Containing Protein Requires Exogenous Processing Neil Blake, Steven Lee, Irina Redchenko, Immunity Adaptive Immune SystemEbv Ebna1ImmunologyHla ClassAntigen Processing	1997	257
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma Mark R. Middleton, Cheryl McAlpine, Victoria K. Woodcock, Clinical Cancer Research	2020	254
A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors Eric Angevin, Josep Tabernero, Élena Elez, Clinical Cancer Research	2014	198

Page 1